Global Latent Tuberculosis Infection (LTBI) Testing Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)世界の潜在性結核感染症(LTBI)検査市場:COVID-19の影響を考慮した洞察と予測(2021-2025年) この調査レポートは世界の潜在性結核感染症(LTBI)検査市場を分析・予測したKoncept Analytics の市場調査報告書です。 Overview The global latent tuberculosis infection (LTBI) testing market is es... もっと見る
Summaryこの調査レポートは世界の潜在性結核感染症(LTBI)検査市場を分析・予測したKoncept Analytics の市場調査報告書です。 Overview The global latent tuberculosis infection (LTBI) testing market is estimated to reach US$2.20 billion in 2025, witnessing growth at a CAGR of 5.89% for the period spanning from 2021 to 2025. The factors such as increase in ageing population, rising awareness of tuberculosis, upsurge in cigarette consumption, urbanization leading to monitoring and screening procedures, surging prevalence of HIV and growth in pharmaceutical research and development. However, growth of the industry will be challenged by multidrug resistant tuberculosis, stringent government regulations, lack of awareness in emerging markets and lack of laboratory facilities. A few notable trends include increasing healthcare expenditure in emerging markets, accelerating TB funding, escalating government initiatives and expansion of advanced and hybrid technologies. Table of Contents1. Market Overview1.1 Tuberculosis (TB) 1.2 Types of Tuberculosis (TB) 1.3 Latent Tuberculosis Infection (LTBI) 1.4 Risk Factors of Latent Tuberculosis 1.5 Types of Latent Tuberculosis Infection Testing 1.6 Latent Tuberculosis Infection Testing Segmentation 2. Impact of COVID-19 2.1 Impact on Global Economy 2.2 Impact of COVID-19 on Individual Mobility & Resource Availability 2.3 Higher Risk of COVID-19 on Geriatric Population & Latent TB Treatment 2.4 Effect on Poverty 3. Global LTBI Testing Market 3.1 Global LTBI Testing Market Forecast by Value 3.2 Global LTBI Testing Market Value by Type 3.2.1 Global Tuberculin Skin Test LTBI Testing Market Forecast by Value 3.2.2 Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market Forecast by Value 3.3 Global LTBI Testing Market Value by Region 3.4 Global LTBI Testing Market Forecast by Volume 3.5 Global LTBI Testing Market Volume by Type 3.5.1 Global Tuberculin Skin Test LTBI Testing Market Forecast by Volume 3.5.2 Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market Forecast by Volume 3.6 Global LTBI Testing Market Volume by Region 4. Regional LTBI Testing Market 4.1 The U.S. 4.1.1 The U.S. LTBI Testing Market Forecast by Value 4.1.2 The U.S. LTBI Testing Market Forecast by Volume 4.2 China 4.2.1 China LTBI Testing Market Forecast by Value 4.2.2 China LTBI Testing Market Forecast by Volume 4.3 Asia-Pacific (Excluding Japan and China) 4.3.1 Asia-Pacific (excluding Japan and China) LTBI Testing Market Forecast by Value 4.3.2 Asia-Pacific (excluding Japan and China) LTBI Testing Market Forecast by Volume 4.4 Europe and Middle East 4.4.1 Europe and Middle East LTBI Testing Market Forecast by Value 4.4.2 Europe and Middle East LTBI Testing Market Forecast by Volume 4.5 Latin America 4.5.1 Latin America LTBI Testing Market Forecast by Value 4.5.2 Latin America LTBI Testing Market Forecast by Volume 4.6 Japan 4.6.1 Japan LTBI Testing Market Forecast by Value 4.6.2 Japan LTBI Testing Market Forecast by Volume 5. Market Dynamics 5.1 Growth Drivers 5.1.1 Increase in Ageing Population 5.1.2 Rising Awareness of Tuberculosis 5.1.3 Upsurge in Cigarette Consumption 5.1.4 Urbanization leading to Monitoring and Screening Procedures 5.1.5 Surging Prevalence of HIV 5.1.6 Growth in Pharmaceutical Research and Development 5.2 Key Trends & Developments 5.2.1 Increasing Healthcare Expenditure in Emerging Markets 5.2.2 Accelerating TB Funding 5.2.3 Escalating Government Initiatives 5.2.4 Expansion of Advanced and Hybrid Technique 5.2.5 Line Probe Assays (LPAs) 5.2.6 Nucleic Acid Amplification Tests (NAATs) 5.3 Challenges 5.3.1 Multidrug Resistant Tuberculosis (MDR-TB) 5.3.2 Stringent Government Regulations 5.3.3 Lack of Awareness in Emerging Markets 5.3.4 Lack of Laboratory Facilities 6. Competitive Landscape 6.1 Global Market 6.1.1 Revenue Comparison of Key Players 6.1.2 Market Capitalization Comparison of Key Players 6.1.3 R&D Comparison of Key Players 7. Company Profiles 7.1 Qiagen N.V. 7.1.1 Business Overview 7.1.2 Financial Overview 7.1.3 Business Strategies 7.2 Abbott Laboratories 7.2.1 Business Overview 7.2.2 Financial Overview 7.2.3 Business Strategies 7.3 Becton, Dickinson and Company 7.3.1 Business Overview 7.3.2 Financial Overview 7.3.3 Business Strategies 7.4 BioMerieux SA 7.4.1 Business Overview 7.4.2 Financial Overview 7.4.3 Business Strategies 7.5 Roche Holding AG 7.5.1 Business Overview 7.5.2 Financial Overview 7.5.3 Business Strategies 7.6 Thermo Fisher Scientific Inc. Inc 7.6.1 Business Overview 7.6.2 Financial Overview 7.6.3 Business Strategies 7.7 Oxford Immunotec Global PLC 7.7.1 Business Overview 7.7.2 Financial Overview 7.7.3 Business Strategies List of Figures Symptoms of TB Types of TB Risk Factors of Latent Tuberculosis Types of Latent Tuberculosis Infection Testing Latent Tuberculosis Infection Testing Segmentation Global Poverty Rate (2014-2021) Global LTBI Testing Market Forecast by Value (2018-2025) Global LTBI Testing Market Value by Type (2020) Global Tuberculin Skin Test LTBI Testing Market Forecast by Value (2018-2025) Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market Forecast by Value (2018-2025) Global LTBI Testing Market Value by Region (2020) Global LTBI Testing Market Forecast by Volume (2018-2025) Global LTBI Testing Market Volume by Type (2020) Global Tuberculin Skin Test LTBI Testing Market Forecast by Volume (2018-2025) Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market Forecast by Volume (2018-2025) Global LTBI Testing Market Volume by Region (2020) The U.S. LTBI Testing Market Forecast by Value (2018-2025) The U.S. LTBI Testing Market Forecast by Volume (2018-2025) China LTBI Testing Market Forecast by Value (2018-2025) China LTBI Testing Market Forecast by Volume (2018-2025) Asia-Pacific (excluding Japan and China) LTBI Testing Market Forecast by Value (2018-2025) Asia-Pacific (excluding Japan and China) LTBI Testing Market Forecast by Volume (2018-2025) Europe and Middle East LTBI Testing Market Forecast by Value (2018-2025) Europe and Middle East Mark LTBI Testing Market Forecast by Volume (2018-2025) Latin America LTBI Testing Market Forecast by Value (2018-2025) Latin America LTBI Testing Market Forecast by Volume (2018-2025) Japan LTBI Testing Market Forecast by Value (2018-2025) Japan LTBI Testing Market Forecast by Volume (2018-2025) Global Ageing Population - Above 60+ (2021-2030) Global Literacy Rate (2016-2020) Global Cigarette Consumption (2014-2020) Global Urban Population (2010-2030) Total Number of People Living with HIV Worldwide (2015-2020) Global Pharmaceutical Research and Development Expenditures (2021-2030) Global Healthcare Expenditure (1995-2022) The U.S. Funding for Global Tuberculosis (TB) (2016-2021) Qiagen N.V. Net Sales and Net Income (Loss) (2016-2020) Qiagen N.V. Net Sales by Region (2020) Abbott Laboratories Net Sales and Net Earnings (2016-2020) Abbott Laboratories Net Sales by Segment (2020) Abbott Laboratories Net Sales by Region (2020) Becton, Dickinson and Company Revenue and Net Income (2016-2020) Becton, Dickinson and Company Revenue by Segment (2020) Becton, Dickinson and Company Revenue by Region (2020) BioMerieux SA Sales and Net Income (2016-2020) BioMerieux SA Sales by Segment (2020) BioMerieux SA Sales by Region (2020) Roche Holding AG Sales and Net Income (2016-2020) Roche Holding AG Sales by Segment (2020) Roche Holding AG Sales by Region (2020) Thermo Fisher Scientific Inc. Revenue and Net Income (2016-2020) Thermo Fisher Scientific Inc. Revenue by Segment (2020) Thermo Fisher Scientific Inc. Revenue by Region (2020) Oxford Immunotec Global PLC Revenue and Net Income (Loss) (2015-2019) Oxford Immunotec Global PLC Revenue by Segment (2019) Oxford Immunotec Global PLC Revenue by Region (2019) List of Tables Differences between Latent TB and Active TB Current LPA products and Associated Equipment NAAT-based Technologies Revenue Comparison of Key Players (2019/2020) Market Capitalization Comparison of Key Players (2021) R&D Comparison of Key Players (2019/2020)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗生物薬)の最新刊レポート
Koncept Analytics 社の最新刊レポート
本レポートと同じKEY WORD(tuberculosis)の最新刊レポートよくあるご質問Koncept Analytics社はどのような調査会社ですか?Koncept Analyticsは世界の農業、金融、観光業など世界の様々な産業を対象とした調査を行うインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/07/05 10:26 162.17 円 175.82 円 209.73 円 |